Brian C. Evanko
Brian C. Evanko's purchase track record
Brian C. Evanko has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/4/2026 | TNET | $189K | +24.0% | +85.0% | +11.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
TriNet Expands Embedded HR Solutions and AI for SMBs. TriNet announced it is adding embedded HR solutions and new AI features aimed at small and medium‑sized businesses. The move broadens the company’s product lineup and could help it capture more of the growing HR‑tech market. The update comes as the stock trades near its 52‑week high and around key support levels.
Transaction History
| CI | ▲ Buy | Grant | 3,113 | $0 | 9/1/2026 | View on chart |
| TNET | ▲ Buy | Grant | 4,735 | $0 | 5/28/2026 | View on chart |
| TNET | ▲ Buy | Open Market | 5,000 | $189K | 3/4/2026 | View on chart |
| CI | ▲ Buy | Grant | 9,787 | $0 | 2/27/2026 | View on chart |
| CI | ▼ Sell | Tax Withholding | 2,979 | $857K | 2/27/2026 | View on chart |
| CI | ▲ Buy | Grant | 6,428 | $0 | 2/27/2026 | View on chart |
| CI | ▼ Sell | Tax Withholding | 1,788 | $514K | 2/27/2026 | View on chart |
| CI | ▲ Buy | Option Exercise | 901 | $125K | 10/6/2025 | View on chart |
| CI | ▲ Buy | Option Exercise | 5,368 | $747K | 10/3/2025 | View on chart |
| CI | ▼ Sell | Open Market | 5,368 | $1.6M | 10/3/2025 | View on chart |
| TNET | ▲ Buy | Grant | 2,649 | $0 | 5/23/2025 | View on chart |
| CI | ▲ Buy | Grant | 12,254 | $0 | 2/28/2025 | View on chart |
| CI | ▲ Buy | Grant | 5,395 | $0 | 2/28/2025 | View on chart |
| CI | ▼ Sell | Tax Withholding | 1,722 | $527K | 2/28/2025 | View on chart |
| CI | ▼ Sell | Tax Withholding | 5,679 | $1.7M | 2/28/2025 | View on chart |
| TNET | ▲ Buy | Grant | 1,916 | $0 | 7/8/2024 | View on chart |
| CI | ▲ Buy | Option Exercise | 1,011 | $122K | 6/25/2024 | View on chart |
| CI | ▲ Buy | Option Exercise | 4,795 | $580K | 6/24/2024 | View on chart |
| CI | ▼ Sell | Open Market | 4,795 | $1.7M | 6/24/2024 | View on chart |
| CI | ▲ Buy | Grant | 8,329 | $0 | 3/1/2024 | View on chart |
| CI | ▼ Sell | Tax Withholding | 1,575 | $525K | 3/1/2024 | View on chart |
| CI | ▼ Sell | Tax Withholding | 3,860 | $1.3M | 3/1/2024 | View on chart |
| CI | ▲ Buy | Grant | 5,127 | $0 | 2/28/2024 | View on chart |
| CI | ▲ Buy | Option Exercise | 570 | $44K | 8/3/2023 | View on chart |
| CI | ▲ Buy | Option Exercise | 2,307 | $180K | 8/2/2023 | View on chart |
| CI | ▼ Sell | Open Market | 2,307 | $692K | 8/2/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 1,342 | $388K | 3/1/2023 | View on chart |
| CI | ▲ Buy | Grant | 6,759 | $0 | 2/24/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 348 | $102K | 2/24/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 2,792 | $822K | 2/24/2023 | View on chart |
| CI | ▲ Buy | Grant | 4,403 | $0 | 2/22/2023 | View on chart |
| CI | ▼ Sell | Tax Withholding | 607 | $144K | 3/1/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 599 | $138K | 2/25/2022 | View on chart |
| CI | ▼ Sell | Tax Withholding | 767 | $176K | 2/25/2022 | View on chart |
| CI | ▲ Buy | Grant | 2,447 | $0 | 2/25/2022 | View on chart |
| CI | ▲ Buy | Grant | 4,750 | $0 | 2/23/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cigna Focuses on Data-Driven Care and Valuation Metrics
Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.
Cigna Focuses on Data-Driven Care and Valuation Metrics. Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.